-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexaria Bioscience Achieves Primary Endpoint in GLP-1 Clinical Study with DehydraTECH Outperforming Rybelsus

Reuters·12/23/2025 14:29:15

Please log in to view news